Bristol-Myers Squibb buy BiotechBee
Start price
07.09.22
/
70%
€69.37
Target price
31.12.25
€100.00
Performance (%)
-12.07%
End price
05.05.23
€61.00
Summary
This prediction ended on 05.05.23 with a price of €61.00. The prediction for Bristol-Myers Squibb disappointed with a performance of -12.07%. A total of €1.61 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | -1.811% | -1.811% | 14.071% | -18.597% |
| iShares Core DAX® | -1,50 % | 7,70 % | 5,24 % | 46,96 % |
| iShares Nasdaq 100 | 1,38 % | 16,28 % | 36,09 % | 95,84 % |
| iShares Nikkei 225® | -1,99 % | 13,11 % | 40,18 % | 62,92 % |
| iShares S&P 500 | 0,35 % | 10,82 % | 26,47 % | 67,25 % |
According to BiotechBee what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy mit Kursziel 100,0